Document Detail


The safety profile of exogenous insulin in people with type 2 diabetes: justification for concern.
MedLine Citation:
PMID:  21736688     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
There is no doubt about the value of exogenous insulin for people with type 1 diabetes. The purpose of this commentary is to discuss emerging evidence that this may not be the case for the majority of people with type 2 diabetes.
Authors:
Craig J Currie; Jeffrey A Johnson
Related Documents :
12145178 - Effects of mesangium glycation on matrix metalloproteinase activities: possible role in...
2351038 - Impaired agglutination of igm resulting from non-enzymatic glycation in diabetes mellitus.
10689668 - Matrix-assisted laser desorption/ionization mass spectrometry, enzymatic digestion, and...
7612018 - Histones from diabetic rats contain increased levels of advanced glycation end products.
7527418 - Changes in circulating insulin-like growth factor-binding protein-1 (igfbp-1) during pr...
12145178 - Effects of mesangium glycation on matrix metalloproteinase activities: possible role in...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-7-7
Journal Detail:
Title:  Diabetes, obesity & metabolism     Volume:  -     ISSN:  1463-1326     ISO Abbreviation:  -     Publication Date:  2011 Jul 
Date Detail:
Created Date:  2011-7-8     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100883645     Medline TA:  Diabetes Obes Metab     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
© 2011 Blackwell Publishing Ltd.
Affiliation:
Reader in Diabetes Pharmacoepidemiology, School of Medicine, Cardiff University, Cardiff, United Kingdom Professor and Canada Research Chair, School of Public Health, University of Alberta, Edmonton, Canada.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Reducing cardiovascular disease risk in patients with type 2 diabetes and concomitant macrovascular ...
Next Document:  Tigerinin-1R: a potent, non-toxic insulin-releasing peptide isolatedfrom the skin of the Asian frog,...